Size the market and pressure-test commercial entry options before you commit channel spend
20+ Years of Multinational Pharmaceutical Experience
Our experts in Go-to-Market & Commercial Growth Consultancy bring more than twenty years of proven track records in Asia's healthcare and life-science industry, with combined executive backgrounds from:
Global Pharmaceutical Leaders
Key points: SmithKline Beecham (GSK); Johnson & Johnson (J&J).
Healthcare & Life Sciences
They bring valuable skillsets in marketing communications, product and commercial launch strategies, distributor search and connection to deliver growth transformation to your business across Asian markets.
PECAN.Solutions supports companies seeking geographic expansion for their healthcare products across the full spectrum of pharmaceutical and healthcare categories:
Medical devices and consumer health go-to-market
Device and consumer-health launches need the same commercial discipline as Rx—clear sizing, a credible partner plan, and promotion that survives local review.
How we support the launch stack
Shape product development and launch sequencing with local realities in mind
Build go-to-market growth plans with partners who can actually execute
Review advertisement and promotion against local rules before campaigns go live
Multinational Pharmaceutical Experience
Leadership team with 20+ years at GSK, Pfizer, J&J, Novartis and other industry leaders brings proven strategies and deep market knowledge.
Comprehensive Asian Network
Established relationships with key distributors, healthcare providers, and regulatory bodies across major Asian markets.
Commercial access that turns approval into revenue
Registration without channel access is only half a launch. We connect market analysis, distributor partnerships, and commercial launch craft so East–West teams negotiate with shared expectations and shorter time from go-decision to first sale.
Outcomes we aim for
Successful entries across diverse healthcare categories
One desk from analysis through ongoing commercial support
Cultural bridging that keeps partnerships durable
Compressed timelines from decision to launch
Talk to the commercial desk
If Asian market complexity is slowing expansion, our commercial access team—rooted in multinational pharmaceutical operating experience—is ready to map the next move and help you grow with discipline.
Our team documents assumptions, authority expectations, and decision points so sponsors can approve the plan with clear risk ownership.
Local pharmacists and regulatory specialists stay accountable through query cycles, inspection readiness, and post-approval obligations.
We align labeling, Module 1 localization, and partner communications so commercial launch can follow approval without rework.
Where pathways differ by product class, we sequence filings to protect the critical path and avoid avoidable deficiency letters.
Engagements can scale from a single dossier workstream to a multi-country virtual regulatory function.
PECAN.Solutions scopes each workstream with milestones, document owners, and authority touchpoints so registration, license holding, and commercial access stay on one plan.
Our team documents assumptions, authority expectations, and decision points so sponsors can approve the plan with clear risk ownership.
Local pharmacists and regulatory specialists stay accountable through query cycles, inspection readiness, and post-approval obligations.
Engagement notes
- We align labeling, Module 1 localization, and partner communications so commercial launch can follow approval without rework
- Where pathways differ by product class, we sequence filings to protect the critical path and avoid avoidable deficiency letters
- Engagements can scale from a single dossier workstream to a multi-country virtual regulatory function
- PECAN.Solutions scopes each workstream with milestones, document owners, and authority touchpoints so registration, license holding, and commercial access stay on one plan
- Our team documents assumptions, authority expectations, and decision points so sponsors can approve the plan with clear risk ownership
- Local pharmacists and regulatory specialists stay accountable through query cycles, inspection readiness, and post-approval obligations